Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Acelyrin Inc (SLRN)

Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Alumis Stockholders Approve Merger with ACELYRIN GlobeNewswire - Tue May 13, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases GlobeNewswire - Tue May 13, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis GlobeNewswire - Tue May 6, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis GlobeNewswire - Thu May 1, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
Alumis and ACELYRIN Announce Amended Merger Agreement GlobeNewswire - Mon Apr 21, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
Alumis and ACELYRIN Announce Amended Merger Agreement GlobeNewswire - Mon Apr 21, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger GlobeNewswire - Fri Apr 4, 2025

SLRN : 2.27 (+1.79%)
ALMS : 22.82 (-7.35%)
ACELYRIN Adopts Limited-Duration Stockholder Rights Plan GlobeNewswire - Thu Mar 13, 2025

SLRN : 2.27 (+1.79%)
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger GlobeNewswire - Tue Mar 4, 2025

SLRN : 2.27 (+1.79%)
ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger GlobeNewswire - Tue Mar 4, 2025

SLRN : 2.27 (+1.79%)

Barchart Exclusives

Marvell Technology Has a Hidden Growth Engine That Could Cause MRVL Stock to Skyrocket Barchart - 34 minutes ago
Optical networking is becoming increasingly relevant, and Marvell has revised its interconnects growth expectations to 50% for FY27. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.